Back to DSKYFView Full LandscapeView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
14 competitors in Non-small Cell Lung Cancer
REGNLibtayo
Phase 3MRKArm A: Pemetrexed Cisplatin
Phase 2SNYoxaliplatine / gemcitabine / Vinorelbine
Phase 2RHHBYerlotinib HCl
Phase 2BNTXBNT327
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Olmesartan medoxomil tablets high dosePhase 3
Metabolic Syndrome
Platinum ChemotherapyPhase 3
Non-small Cell Lung Cancer
Edoxaban tablets (low dose regimen-30mg)Phase 3
Stroke
Edoxaban tablets (high dose regimen-60mg)Phase 3
Stroke
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tabletsPhase 3
Essential Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
